In the fourth of a series of conversations at last week’s ViVE health-tech event, MM+M’s Marc Iskowitz sat down with KKR’s Christopher McFadden to discuss how private equity firms have upped their investments in health marketing agencies in recent years — a trend that has barely started yet — and to chart out a course for the next set of big-money deals.